APA

Wang H. Q., Halilovic E., Li X., Liang J., Cao Y., Rakiec D. P., Ruddy D. A., Jeay S., Wuerthner J. U., Timple N., Kasibhatla S., Li N., Williams J. A., Sellers W. R., Huang A. & Li F. (20180212). Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human. : eLife.

Chicago

Wang Hui Qin, Halilovic Ensar, Li Xiaoyan, Liang Jinsheng, Cao Yichen, Rakiec Daniel P, Ruddy David A, Jeay Sebastien, Wuerthner Jens U, Timple Noelito, Kasibhatla Shailaja, Li Nanxin, Williams Juliet A, Sellers William R, Huang Alan and Li Fang. 20180212. Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human. : eLife.

Harvard

Wang H. Q., Halilovic E., Li X., Liang J., Cao Y., Rakiec D. P., Ruddy D. A., Jeay S., Wuerthner J. U., Timple N., Kasibhatla S., Li N., Williams J. A., Sellers W. R., Huang A. and Li F. (20180212). Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human. : eLife.

MLA

Wang Hui Qin, Halilovic Ensar, Li Xiaoyan, Liang Jinsheng, Cao Yichen, Rakiec Daniel P, Ruddy David A, Jeay Sebastien, Wuerthner Jens U, Timple Noelito, Kasibhatla Shailaja, Li Nanxin, Williams Juliet A, Sellers William R, Huang Alan and Li Fang. Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human. : eLife. 20180212.